Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review

• Main Authors: Chisato Yoshijima, BSPharm (Author), Yosuke Suzuki, PhD (Author), Ayako Oda, BSPharm (Author), Ryota Tanaka, PhD (Author), Hiroyuki Ono, BSPharm (Author), Hiroki Itoh, PhD (Author), Keiko Ohno, PhD (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Belimumab is the first antibody drug approved for systemic lupus erythematosus (SLE), and is a fully human monoclonal antibody that inhibits soluble B lymphocyte stimulator protein. In clinical trials, a composite index was used to assess efficacy of belimumab. However, clinical guidelin...